Retraction
Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
Paper Information
Record ID:
35993
Author(s):
Publication Date:
July 05, 2021
Retraction Date:
March 09, 2022
(3.7 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/S1470-2045(22)00064-XAdditional Notes:
see: https://www.sciencedirect.com/science/article/abs/pii/S1470204522000663;
Citations (61)
61
Total Citations50
Post-Retraction(82.0%)
11
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
23
Within 1 year
8
After 2+ years
1225
Days since retraction (latest)
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy
Shunsuke A. Sakai, Hidekazu Oyoshi, Masaki Nakamura et al. (24 authors)
British Journal of Cancer
Open Access
Published: Jul 2025
1225 days after retraction
DCLRE1B as a novel prognostic biomarker associated with immune infiltration: a pancancer analysis
Mi Zou, Zuxi Feng, Kaibo Hu et al. (13 authors)
Scientific Reports
Open Access
Published: Dec 2024
1027 days after retraction
First-line treatment with KN046, chemotherapy and palliative radiotherapy for advanced esophageal squamous cell carcinoma: an open-label, dose escalation, and dose expansion phase Ib trial
Qi Zhao, Xi Su, Jiao Xue et al. (7 authors)
Cancer Immunology Immunotherapy
Open Access
Published: Aug 2024
3 citations
3 citations
881 days after retraction
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study
Iris W.J.M. van Goor, Paul C M Andel, F Buijs et al. (27 authors)
Annals of Surgical Oncology
Open Access
Published: Jun 2024
1 citation
1 citation
841 days after retraction
Postoperative tumor treatment strategies: From basic research to clinical therapy
Minna Xiao, Lin Wang, Qinglai Tang et al. (8 authors)
View
Open Access
Published: May 2024
7 citations
7 citations
812 days after retraction
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang et al. (10 authors)
Frontiers in Immunology
Open Access
Published: May 2024
18 citations
18 citations
785 days after retraction
Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma
Meiyan Zhu, Meng Jin, Xiao Zhao et al. (10 authors)
BMC Medicine
Open Access
Published: Apr 2024
7 citations
7 citations
772 days after retraction
Eradicating gross tumor disease: a prerequisite for efficient radioimmunotherapy?
Éric Deutsch, Antonin Lévy
JNCI Journal of the National Cancer Institute
Open Access
Published: Mar 2024
2 citations
2 citations
749 days after retraction
Clinical immunotherapy in pancreatic cancer
Xiaorong Ye, Yue Yu, Xiaohu Zheng et al. (4 authors)
Cancer Immunology Immunotherapy
Open Access
Published: Mar 2024
24 citations
24 citations
724 days after retraction
Global research landscape and trends of cancer radiotherapy plus immunotherapy: A bibliometric analysis
Yanhao Liu, Xu Jiang, Yujuan Wu et al. (4 authors)
Heliyon
Open Access
Published: Feb 2024
4 citations
4 citations
720 days after retraction
A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda
European Journal of Pharmacology
Published: Feb 2024
4 citations
4 citations
717 days after retraction
Stereotactic body radiotherapy for pancreatic cancer – A systematic review of prospective data
M. Shouman, Frederik Fuchs, Franziska Walter et al. (11 authors)
Clinical and Translational Radiation Oncology
Open Access
Published: Jan 2024
11 citations
11 citations
690 days after retraction
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang et al. (16 authors)
International Journal of Radiation Oncology*Biology*Physics
Published: Jan 2024
14 citations
14 citations
667 days after retraction
Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review
Maryam Noori, Farideh Jafari‐Raddani, Zeinab Davoodi‐Moghaddam et al. (6 authors)
Cancer Cell International
Open Access
Published: Jan 2024
10 citations
10 citations
667 days after retraction
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Jan 2024
27 citations
27 citations
664 days after retraction
Strahlentherapie
Matthias Lampe, R. Krempien, Marc Münter
Springer eBooks
Published: Jan 2024
663 days after retraction
Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy
Han Zhang, Wenjin Xu, Haitao Zhu et al. (5 authors)
Journal of Cancer
Open Access
Published: Jan 2024
6 citations
6 citations
663 days after retraction
Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma
Hidekazu Oyoshi, Junyan Du, Shunsuke A. Sakai et al. (22 authors)
Science Advances
Open Access
Published: Dec 2023
19 citations
19 citations
644 days after retraction
Effect and Mechanism of Curdione Combined with Gemcitabine on Migration and Invasion of Bladder Cancer
Bao‐Jin Chi, Zhong-Lei Duan, Al-Kamel Haithm Ali Mohammed Hasan et al. (6 authors)
Biochemical Genetics
Published: Dec 2023
636 days after retraction
Potential therapies targeting nuclear metabolic regulation in cancer
Yanjie Chen, Jie Xu, Xiaoyi Liu et al. (6 authors)
MedComm
Open Access
Published: Nov 2023
8 citations
8 citations
630 days after retraction
Alpha‐Emitter Radium‐223 Induces STING‐Dependent Pyroptosis to Trigger Robust Antitumor Immunity
Mengdie Yang, Haipeng Liu, Jingjing Lou et al. (16 authors)
Small
Open Access
Published: Oct 2023
12 citations
12 citations
586 days after retraction
Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy
Astrid Z. Johansen, Sif I. Novitski, Jessica Xin Hjaltelin et al. (9 authors)
Frontiers in Immunology
Open Access
Published: Sep 2023
4 citations
4 citations
547 days after retraction
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer
Open Access
Published: Jul 2023
48 citations
48 citations
502 days after retraction
Holistic anti-tumor resistance mechanism of YBX1 and its potential as a chemoresistance target in pancreatic ductal adenocarcinoma
Zheng Li, Haidi Chen, Borui Li et al. (8 authors)
Holistic Integrative Oncology
Open Access
Published: Jun 2023
2 citations
2 citations
454 days after retraction
The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating
Yize Mao, Hui Xie, Min‐Yi Lv et al. (9 authors)
Cancer Immunology Immunotherapy
Published: Apr 2023
16 citations
16 citations
393 days after retraction
Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study
Xiuping Zhang, Shuai Xu, Yuan‐Xing Gao et al. (9 authors)
International Journal of Surgery
Open Access
Published: Mar 2023
26 citations
26 citations
387 days after retraction
Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
Shuling Chen, Jiaxin Li, Aoran Dong et al. (11 authors)
Journal of Hematology & Oncology
Open Access
Published: Mar 2023
9 citations
9 citations
376 days after retraction
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
Stephanie Kroeze, Matea Pavic, Karin Stellamans et al. (34 authors)
The Lancet Oncology
Published: Feb 2023
115 citations
115 citations
355 days after retraction
Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer
Jiaxing Du, Yongsheng Chen, Genglong Liu et al. (6 authors)
Pathology - Research and Practice
Open Access
Published: Feb 2023
1 citation
1 citation
340 days after retraction
Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
Xin Qiu, Zhan Shi, Fan Tong et al. (11 authors)
Human Vaccines & Immunotherapeutics
Open Access
Published: Jan 2023
15 citations
15 citations
299 days after retraction
Toxicity When Combining Immunotherapy and Radiotherapy
O. Leaman-Alcibar, Fernando López‐Campos, Javier Aller et al. (7 authors)
Springer eBooks
Published: Jan 2023
298 days after retraction
Local Ablative Therapies and the Effect on Antitumor Immune Responses in Pancreatic Cancer – a Review
Suna Erdem, Jayanth Narayanan, Mathias Worni et al. (5 authors)
Unknown Journal
Published: Jan 2023
298 days after retraction
Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
Qingfang Li, Zhihui Li, Ting Luo et al. (4 authors)
Molecular Biomedicine
Open Access
Published: Dec 2022
132 citations
132 citations
287 days after retraction
Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma
Malvi Savani, Rachna T. Shroff
Hematology/Oncology Clinics of North America
Published: Oct 2022
2 citations
2 citations
206 days after retraction
Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
Wanting Hou, Biao Yang, Hong Zhu
Pharmaceutics
Open Access
Published: Sep 2022
14 citations
14 citations
199 days after retraction
Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Sep 2022
77 citations
77 citations
198 days after retraction
Uniform expansion vs. non-uniform expansion of gross tumor volume based on recurrence patterns to form planning target volume of stereotactic body radiation therapy for locally advanced pancreatic cancer: protocol of a randomized phase II study
Lingong Jiang, Xiaofei Zhu, Haiyan Yu et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Aug 2022
155 days after retraction
Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights
Jiaojiao Ni, Zizhen Zhang, Ming-jie Ge et al. (5 authors)
Acta Pharmacologica Sinica
Open Access
Published: Aug 2022
43 citations
43 citations
148 days after retraction
Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells
Wei Cao, Guodong Chen, Lijun Wu et al. (11 authors)
International Journal of Radiation Oncology*Biology*Physics
Published: Jul 2022
44 citations
44 citations
144 days after retraction
Efficacy of stereotactic body radiation therapy for locoregional recurrent pancreatic cancer after radical resection
Xiaoqin Ji, Bin Zhou, Wei Ding et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Jul 2022
2 citations
2 citations
135 days after retraction
Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases
Guoxiao Zhang, Bo Li, Xiaoyi Yin et al. (16 authors)
International Journal of Surgery
Published: Jul 2022
5 citations
5 citations
132 days after retraction
Risk of Rash in PD-1 or PD-L1-Related Cancer Clinical Trials: A Systematic Review and Meta-Analysis
Yuan Tian, Chi Zhang, Qi Dang et al. (13 authors)
Journal of Oncology
Open Access
Published: Jul 2022
6 citations
6 citations
131 days after retraction
Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies
Elizabeth Guimond, C. Jillian Tsai, Ali Hosni et al. (6 authors)
Advances in Radiation Oncology
Open Access
Published: Jul 2022
22 citations
22 citations
127 days after retraction
Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy
Jin Wang, Xingchen Liu, Junsong Ji et al. (9 authors)
Frontiers in Immunology
Open Access
Published: Jul 2022
27 citations
27 citations
120 days after retraction
Deep Learning for Fully Automated Prediction of Overall Survival in Patients Undergoing Resection for Pancreatic Cancer
Jiawen Yao, Kai Cao, Yang Hou et al. (23 authors)
Annals of Surgery
Published: Jul 2022
25 citations
25 citations
117 days after retraction
Clinical evidence for synergy between immunotherapy and radiotherapy (<scp>SITAR</scp>)
Suki Gill, Anna K. Nowak, Samantha Bowyer et al. (6 authors)
Journal of Medical Imaging and Radiation Oncology
Open Access
Published: Jun 2022
12 citations
12 citations
97 days after retraction
Comprehensive Analysis of Necroptosis in Pancreatic Cancer for Appealing its Implications in Prognosis, Immunotherapy, and Chemotherapy Responses
Kun Fang, Desheng Tang, Changsheng Yan et al. (7 authors)
Frontiers in Pharmacology
Open Access
Published: May 2022
8 citations
8 citations
70 days after retraction
Immunotherapy for patients with pancreatic adenocarcinoma
Stanislav John
Onkologie
Published: May 2022
68 days after retraction
The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy
Yu‐Hsuan Hung, Li‐Tzong Chen, Wen‐Chun Hung
Biomedicines
Open Access
Published: Apr 2022
1 citation
1 citation
40 days after retraction
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
Zheng Gao, Jiafeng Chen, Xiaogang Li et al. (16 authors)
Cancer Cell International
Open Access
Published: Mar 2022
25 citations
25 citations
10 days after retraction
Quick Stats
Total Citations:
61
Years Since Retraction:
3.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025